Clinical Chemistry 2
Clinical Chemistry 2
OVERVIEW: pathways:
● CARBOHYDRATES PATHWAYS DESCRIPTION
● LIPIDS & LIPOPROTEINS Metabolism of glucose molecule
● NON-PROTEIN NITROGEN GLYCOLYSIS to pyruvate or lactate for
● CLINICAL ENZYMOLOGY production of energy
● ELECTROLYTES Formation of glucose-6-phosphate
GLUCONEOGENESIS
● LIVER FUNCTION from non-carbohydrate source
● KIDNEY FUNCTION Breakdown of glycogen to glucose
GLYCOGENOLYSIS
● ENDOCRINOLOGY for use as energy
Conversion of glucose to glycogen
GLYCOGENESIS
CARBOHYDRATES for storage
● Contains Carbon, Hydrogen, and Oxygen Conversion of carbohydrates to
LIPOGENESIS
● Major source of stored and used energy fatty acids
● Component of cell membranes LIPOLYSIS Decomposition of fat
● Structural component in plants, bacteria, insects
● Can be reducing or non-reducing sugars HORMONES INVOLVED IN CARBOHYDRATE
● Classified according to the number of sugar units: METABOLISM
1. INSULIN
SUGAR SUGAR EXAMPLES ◆ produced by beta cells islets of Langerhans
UNIT ◆ targets most cells of the body
Glucose, Fructose, ◆ increases utilization of glucose by cells by
Monosaccharides 1 unit
Galactose increasing cellular uptake and hepatic glycolysis
Glucose + 2. GLUCAGON
Sucrose
Fructose ◆ produced by alpha cells of the islets of
Glucose + Langerhans
Disaccharides 2 units Lactose
Galactose ◆ targets the liver
Glucose + 3. CORTISOL
Maltose
Glucose ◆ glucocorticoids
3 to 10 ◆ increases glucogeneogenesis
Oligosaccharides
units ◆ decreases utilization of glucose by cells by
more Starch, increasing cellular uptake and extrahepatic
Polysaccharides than 10 Glycogen, tissues
units Cellulose ◆ from adrenal cortex
4. CATECHOLAMINES
CARBOHYDRATE METABOLISM ◆ stimulates glycogenolysis
● Glucose is the only carbohydrate to be used directly ◆ from adrenal medulla
for energy 5. THYROID HORMONE
● In an average diet, about 50% of carbohydrates are ◆ inhibit glucose absorption in the small intestine
constituted by calories ◆ from thyroid gland
● Disaccharides are hydrolyzed into monosaccharides 6. SOMATOSTATIN
then absorbed by the gut via active transport or ◆ inhibit glucagon and insulin secretion
facilitated diffusion. They are transported to the liver ◆ from delta cells of pancreas
through portal circulation
● After glucose enters cell, it undergoes 7. GROWTH HORMONE
phosphorylation into glucose-6-phosphate through ◆ increases liver gluconeogenesis
the action of hexokinase and glucokinase. ◆ inhibits glycolysis
◆ inhibits glucose transport FASTING 2-HOUR
PLASMA PLASMA
DIAGNOSIS HbA1c
DIABETES MELLITUS GLUCOS GLUCOS
● heterogeneous group of multifactoral, polygenic E E
syndromes characterized by an elevated fasting <140
NORMAL <100 mg/dl
blood glucose caused by a relative or absolute mg/dl
deficiency in insulin 5.7 -
PRE-DIABETES
6.4%
DIABETES TYPE 1 DM TYPE 2 100-125
IMPAIRED FASTING
MELLITUS mg/dl
GLUCOSE
Absolute
deficiency of IMPAIRED GLUCOSE 140-199
insulin caused Combination of TOLERANCE mg/dl
by an insulin resistance DIABETES >200
DESCRIPTION >126 mg/dl >6.5%
autoimmune and dysfunctional MELLITUS mg/dl
attack on the beta cells
beta cells of the ORAL GLUCOSE TOLERANCE TEST
pancreas ● Individuals should ingest atleast 150 g/day of CHO for
● Juvenile 3 days before OGTT
● Adult Onset DM
Onset DM ● Fasting: 8-14 hrs
OTHER NAME ● Non-Insulin-
● Insulin- ● venous sample are preferred - collected in gray top
Dependent
Dependent tube containing fluoride and anticoagulant
FREQUENCY 5 to 10% 90-95% ● FBG is measured before administration of glucose
Most common load
Most common with
AGE OF ONSET in children and ■ Adults: 75 g
advancing age
young adults ■ Children: 1.75/kg body weight max of 75 g
● Genetic ● Genetic ■ Pregnant Women: 75 g ((100g)
● Autoimmune ● Obesity ● Glucose load should be finished within 5-15 minutes
RISK FACTORS
● Environment ● Sedentary ● If patient vomits, discontinue
al Lifestyle
Insulin GLYCOSYLATED HEMOGLOBIN
MEDICATION absolutely Oral agents ● rate of formation of HbA1C is proportional to the
necessary average blood glucose concentration over the
Lifestyle, oral previous 3 months
THERAPHY None known
medicines ● 1% increase HbA1c = 35 mg/dl change in plasma
glucose
GESTATIONAL DIABETES MELLITUS ● tested twice a year = long term glycemic control
● glucose intolerance with onset or first recognition ● collected in EDTA - whole blood spin = hemolysate
during pregnancy
● large percentage of patients develop DM within 5 to HYPOGLYCEMIA
10 years ● about 50-55 mg/dl glucose are released
● infants born to mothers with diabetes are at risk for ● most causes are secondary to other illnesses; resolve
severe complications when primary sickness is treated
● Screening: 2-hour OGTT using a 75 g glucose load. ● warning signs and symptoms are all related to the
CNS
● 5-h OGTT = glucose values strikingly drop around
hours 4 & 5
SPECIMEN CONSIDERATION AND PATIENT FATTY ACIDS
PREPARATION FOR GLUCOSE TESTING ● building blocks o lipids
● Possible specimens = Whole blood, serum, plasma, ● hydrocarbon chains with a terminal COO-
urine CSF, serous fluid, synovial fluid
● Standard clinical specimen = fasting venous plasma TRIGLYCERIDES
sample ● 3 fatty acid molecules attached to one molecule of
● Fasting hours: 8 -10 hours glycerol by ester bonds
● Collection: Gray Top ● serves as main storage form of energy, shock
● Whole Blood Glucose Levels: 10-15% lower than absorber, insulator and integral part of cell
fasting plasma glucose membrane
● Glucose Metabolism: Room Temp - 7 mg/dL/hr; 4C - 2
mg/dL/hr PHOSPHOLIPIDS
● Glucose CSF levels: 60-70% of plasma glucose ● contains non - polar and polar end
● constituent of cell membrane
METHODS FOR GLUCOSE MEASUREMENT
CHOLESTEROL
CHEMICAL METHODS ● serves as part of cell membranes and as parent chain
● Folin- Wu: phosphomolybdate + for cholesterol-based hormones
reduced copper = ● exist in two forms:
OXIDATION- phosphomolybdenum blue ■ Cholesterol esters: approximately 70% of total
REDUCTION ● Nelson - Somogyi: arsenomolybdate + cholesterol
reduced copper = arsenomolybdenum ■ Free Cholesterol: approximately 30% of total
blue cholesterol
ENZYMATIC METHODS
● Colorimetric Method: uses a side LIPOPROTEIN STRUCTURE
CREATININE KINASE
● cardiac muscle, skeletal muscle, brain
● sensitive indicator: Myocardial Infarction
● highest elevation: Duchenne Muscular Dystrophy
● most sensitive enzyme for skeletal muscle disease
● ISOENZYMES:
■ CK-BB
◆ most anodal
◆ highest concentration: CNS
■ CK-MB
◆ value detection in AMI
◆ rise 4-8 hrs, peak 12-24 hrs, normal 48-72
hrs
■ CK-MM
◆ major form in sera of healthy people
◆ hypothyroidism
AMYLASE
● salivary glands, pancreas
● breaks down starch to simple sugar
● increase in acute pancreatitis
LIPASE
● specific for pancrease
● increase in acute pancreatitis
● olive oil substrate is used in determination;
■ modification: triolein
GLUCOSE-6-PHOSPHATE DEHYDROGENASE
● first step of glucose metabolism
● hemolysate = whole blood = measurement
● G6PD Deficiency, drug-induced hemolytic anemia
PSEUDOCHOLINESTERASE
● diagnosis and management of organophosphate
poisoning